These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 29668073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B, Mariotti J, Bramanti S, Morabito L, Crocchiolo R, Rimondo A, Tordato F, Pocaterra D, Casari E, De Philippis C, Carlo-Stella C, Santoro A, Castagna L.
    Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
    [Abstract] [Full Text] [Related]

  • 6. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD, Kourbeti IS, Mylonakis E.
    Clin Ther; 2014 Feb 01; 36(2):292-306.e1. PubMed ID: 24439393
    [Abstract] [Full Text] [Related]

  • 7. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
    Pepeler MS, Yildiz Ş, Yegin ZA, Özkurt ZN, Tunçcan ÖG, Erbaş G, Köktürk N, Kalkanci A, Yildirim Z.
    J Infect Dev Ctries; 2018 Sep 30; 12(9):799-805. PubMed ID: 31999640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
    Biehl LM, Vehreschild JJ, Liss B, Franke B, Markiefka B, Persigehl T, Bücker V, Wisplinghoff H, Scheid C, Cornely OA, Vehreschild MJ.
    J Antimicrob Chemother; 2016 Sep 30; 71(9):2634-41. PubMed ID: 27317443
    [Abstract] [Full Text] [Related]

  • 10. Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation.
    Blennow O, Remberger M, Törlén J, Szakos A, Ljungman P, Mattsson J.
    Biol Blood Marrow Transplant; 2016 Sep 30; 22(9):1684-1689. PubMed ID: 27311967
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC).
    López-Sánchez C, Valcárcel D, Gómez V, López-Jiménez J, Serrano D, Rubio V, Solano C, Vázquez L, Ruiz I, Grupo Español de Trasplante Hematopoyético (GETH).
    Rev Esp Quimioter; 2020 Apr 30; 33(2):110-115. PubMed ID: 32056418
    [Abstract] [Full Text] [Related]

  • 16. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX, Shen JL, Tang XF, Feng B, Xu HQ.
    Eur Rev Med Pharmacol Sci; 2016 Apr 30; 20(2):381-90. PubMed ID: 26875911
    [Abstract] [Full Text] [Related]

  • 17. Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm.
    Chan SY, Hughes RM, Woo K, Perales MA, Neofytos D, Papanicolaou G.
    Med Mycol; 2020 Nov 10; 58(8):1029-1036. PubMed ID: 32171012
    [Abstract] [Full Text] [Related]

  • 18. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
    Kuster S, Stampf S, Gerber B, Baettig V, Weisser M, Gerull S, Medinger M, Passweg J, Schanz U, Garzoni C, Berger C, Chalandon Y, Mueller NJ, van Delden C, Neofytos D, Khanna N, Swiss Transplant Cohort Study.
    Transpl Infect Dis; 2018 Dec 10; 20(6):e12981. PubMed ID: 30144374
    [Abstract] [Full Text] [Related]

  • 19. Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis.
    Wingen-Heimann SM, Cornely OA, Vehreschild MJGT, Wisplinghoff H, Franke B, Schons M, von Bergwelt-Baildon M, Scheid C, Vehreschild JJ.
    Mycoses; 2021 Apr 10; 64(4):437-444. PubMed ID: 33354800
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.